Paratek Pharmaceuticals

$8.16
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.20 (+2.51%) As of 7:31 PM UTC today

Why Robinhood?

You can buy or sell PRTK and other stocks, options, and ETFs commission-free!

About PRTK

Paratek Pharmaceuticals, Inc. engages in the development and commercialization of therapies based upon tetracycline chemistry. Its products include omadacycline and sarecycline, which are used for the treatment of community-acquired bacterial infections, including community-acquired bacterial pneumonia, acute bacterial skin and skin structure infections and urinary tract infections.

CEO
Evan Loh
Employees
197
Headquarters
Boston, Massachusetts
Founded
1996
Market Cap
336.50M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
741.71K
High Today
$8.39
Low Today
$7.95
Open Price
$7.95
Volume
948.85K
52 Week High
$8.75
52 Week Low
$3.81

PRTK Earnings

-$1.05
-$0.70
-$0.35
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 10, After Hours

You May Also Like

PTGX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure